Pharmaceutical Technology Europe-03-01-2005

Pharmaceutical Technology Europe

Taming the Regulatory Beast: Regulation versus Functionalism

March 22, 2005

Regulatory Affairs

17

3

Mass spectrometrists working in pharmaceutical development tend to approach the issue of regulatory compliance with some trepidation...

Field-Flow Fractionation With Multiangle Light Scattering

March 22, 2005

Biopharmaceuticals

17

3

Absolute macromolecular characterization is a separation technique that combines AF-FFF with MALS instruments...

The Application of Cryogenics for Sustainable Solvent Recovery

March 22, 2005

Process Control

17

3

Emissions control has long been a primary concern for the pharmaceutical processing industry in Europe, which relies on the use of a number of organic solvents for the manufacture of pharmaceutical products...

Big Pharma Smells Parallel Trade Victory

March 22, 2005

Talking Point

17

3

European court's "return to common sense" on parallel trade set to save big pharma 3.5 billion euros...

Keeping Supply Chains Healthy

March 22, 2005

Outsourcing

17

3

Today's fast-paced global market place has created a critical need for efficient international supply systems in the healthcare sector...

Current Trends in Biomanufacturing

March 22, 2005

Biopharmaceuticals

17

3

The limited effectiveness of some existing drugs and demand for new therapeutic candidated for complex diseases has spurred the development of the biopharmaceutical market...

Maintenance Qualification: Improving Compliance and Performance in Pharmaceutical Manufacturing

March 22, 2005

Manufacturing Equipment

17

3

This article describes the approach to maintenance management that delivers enhanced compliance for direct impact GMP systems...

The European Search for Research

March 22, 2005

Regulatory Affairs

17

3

If the EU wants to be taken seriously by researchers, it has to start delivering on a climate that really aids research...

European Biotech Second to US

March 21, 2005

Editorial

17

3

The air of optimism surrounding the European biopharmaceutical industry seems to have dissipated...